Question 1

Who are the top researchers at Agenus (United States)?

Accepted Answer

Ranked on the quality score, Nicholas S. Wilson, Antoine J. Tanne and David A. Savitsky lead among researchers whose main affiliation is Agenus (United States).

Question 2

What are the most cited papers from Agenus (United States)?

Accepted Answer

The most cited paper from Agenus (United States) is "Actively personalized vaccination trial for newly diagnosed glioblastoma" (Norbert Hilf et al., 2018), with 954 citations. Next come "Recombinant Glycoprotein Vaccine for the Prevention of Genital HSV-2 Infection" (492) and "An adjuvant autologous therapeutic vaccine (HSPPC-96; vitespen) versus observation alone for patients at high risk of recurrence after nephrectomy for renal cell carcinoma: a multicentre, open-label, randomised phase III trial" (333).

Question 3

Which research topics does Agenus (United States) publish most on?

Accepted Answer

By volume in 2022-now: Cancer Immunotherapy and Biomarkers, CAR-T cell therapy research, Immunotherapy and Immune Responses and Monoclonal and Polyclonal Antibodies Research.

Question 4

Which keywords describe research at Agenus (United States)?

Accepted Answer

By fractional works in 2022-now, weighted toward what it does more of than the world: Tumor Microenvironment, Cancer Immunotherapy, Immune Checkpoint Blockade, PD-1 and PD-L1, Immunotherapy, Tumor Regression, Immunity and Antigen Presentation.

Question 5

Which fields of science does Agenus (United States) work in?

Accepted Answer

In 2022-now, 54% of research at Agenus (United States) is in Health Sciences, 34% in Life Sciences. Its largest fields are Medicine (46%), Immunology and Microbiology (18%), Biochemistry, Genetics and Molecular Biology (14%). It does 1.9× the world's share of Health Sciences.

Question 6

Is Agenus (United States)'s research output growing?

Accepted Answer

Output in 2022-2025 was 3% lower than in 2018-2021.